The Effect of Acceptance and Commitment Therapy in Patients With Chronic Renal Failure

Kidney Failure, Chronic Clinical Trial

Official title:

The Effect of Acceptance and Commitment Therapy-based Psychoeducation Given to Chronic Renal Failure Patients on Illness Adaptation, Psychological Resilience and Life Satisfaction

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT06358534
• Other study ID #: RTEU-SBF-KB-01
• Status: Active, not recruiting
• Phase: N/A
• Start date: June 1, 2023
• Est. completion date: July 30, 2024

Study information

• Verified date: April 2024
• Source: Recep Tayyip Erdogan University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Psychological flexibility, life satisfaction and adaptation to the disease of individuals with chronic kidney disease were increased with psychoeducation based on acceptance and commitment therapy to be given to individuals with chronic kidney disease.

Description:

Chronic renal failure is a condition that affects the kidneys and has long-term consequences for physical, psychological, and social well-being. It reduces quality of life, productivity, and independence, leading to increased costs and the need for care. In order to ensure treatment compliance and maintain living standards, it is important to enhance individuals' readiness for treatment. While there are psychological intervention studies during the treatment process, there are few studies that focus on psychological readiness before dialysis. This study highlights acceptance and determination-based approaches to help individuals become aware of their feelings and thoughts and accept them, minimizing resistance to treatment and improving treatment compliance. By managing negative emotions and thoughts towards the treatment, this study aims to increase disease compliance, provide psychological support during pre-dialysis trainings, diversify the use of acceptance and commitment therapy-based approaches, and promote psychosocial support in chronic diseases in psychiatric nursing practices.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 32
• Est. completion date: July 30, 2024
• Est. primary completion date: November 30, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Acceptance to participate in the research
• Diagnosis of CKD Stage 4-5
• GFR below 29ml/min/1.72m2
• 18 years of age and over
• Being literate
• No barriers to verbal communication
• No psychiatric treatment

Exclusion Criteria:

• Receiving haemodialysis and peritoneal dialysis treatment,
• Pregnancy
• The presence of a psychiatric disorder requiring treatment,
• Individuals with transplantation and rejection transplantation

Related Conditions & MeSH terms

• Kidney Failure, Chronic
• Renal Insufficiency

Intervention

Behavioral:
• psychoeducation based on acceptance and commitment therapy
psychoeducation based on acceptance and commitment therapy prepared by the researchers was applied individually to the patients

Locations

Country	Name	City	State
Turkey	Recep Tayyip Erdogan University Faculty of Health Sciences	Rize	Güneysu

Sponsors (1)

Lead Sponsor	Collaborator
Recep Tayyip Erdogan University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Chronic Disease Adaptation Scale (CHAS):	The scale, which consists of three sub-dimensions (physical adaptation, social adaptation, psychological adaptation) and 25 items, is a 5-point Likert scale (1: Strongly Disagree, 2: Disagree, 3: Undecided, 4: Agree, 5: Strongly Agree).The total score obtained from the scale is 125. The increase in the scores obtained from the sub-dimensions and/or the whole scale means that the patients' level of adaptation to the disease increases.	8 weeks
Primary	Acceptance and Action Questionnaire-II Scale (AAQ-II)	The KEF-II is a 7-point Likert-type self-report scale consisting of a total of 7 items. Scale items are graded from 1 ("Never true") to 7 ("Always true"). The lowest score that can be obtained from the scale is 7 and the highest score is 49. Higher total scores indicate an increase in the level of psychological rigidity, while lower scores indicate an increase in the level of psychological flexibility.	8 weeks
Primary	Life Satisfaction Scale	The scale consisting of five questions is in the form of a five-point Likert scale ranging from '1=not at all appropriate' to '5=very appropriate'. The lowest score that can be obtained from the scale, which has no sub-dimensions, is 5 and the highest score is 25. The high score obtained from the scale indicates a high degree of satisfaction.	8 weeks